Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Helex Secures $3.5M Seed Financing Round
SeedVenture Capital

Helex Secures $3.5M Seed Financing Round

•October 30, 2025
•Oct 30, 2025
0

Participants

Helex

Helex

company

SOSV

SOSV

investor

pi Ventures

pi Ventures

investor

Why It Matters

The financing validates investor confidence in Helex’s novel LNP‑AI approach and provides the resources needed to accelerate drug candidates for high‑unmet‑need kidney disorders, positioning the company for future partnerships or acquisition in the biotech sector.

Deal Summary

Helex, a therapeutics firm focused on genetic kidney diseases, announced an oversubscribed $3.5 million seed round led by pi Ventures with participation from Bluehill Capital, SOSV and a global syndicate of investors. The funding brings Helex's total capital raised to over $6 million, supporting its AI‑driven drug design and LNP delivery platforms.

0

Comments

Want to join the conversation?

Loading comments...